Design Therapeutics (DSGN) Change in Acquisitions & Divestments (2020 - 2026)

Design Therapeutics has disclosed Change in Acquisitions & Divestments across 7 years of filings, most recently posting $45.0 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $45.0 million, down 52.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $265.4 million (down 12.26% YoY), and the FY2025 annual result was $314.9 million, up 14.72% from the prior year.
• Change in Acquisitions & Divestments came in at $45.0 million for Q1 2026 at Design Therapeutics, down from $76.1 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $94.5 million in Q1 2025 to a low of $490000.0 in Q1 2022.
• The 5-year median for Change in Acquisitions & Divestments is $66.2 million (2024), against an average of $59.1 million.
• Peak annual rise in Change in Acquisitions & Divestments reached 30020.0% in 2022, while the deepest fall reached 98.26% in 2022.
• Design Therapeutics' Change in Acquisitions & Divestments stood at $60.2 million in 2022, then jumped by 32.36% to $79.7 million in 2023, then declined by 16.97% to $66.2 million in 2024, then climbed by 14.91% to $76.1 million in 2025, then slumped by 40.85% to $45.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $45.0 million (Q1 2026), $76.1 million (Q4 2025), and $84.6 million (Q3 2025), per Business Quant data.